X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

Proposed HSR Rule Changes to Increase Investment Fund Reporting, Exempt Minority Acquisitions by Activist Investors

On Monday, September 21, 2020, the Federal Trade Commission, with the support of the Department of J...

Read More >

US Treasury and IRS Targets for Audit

On October 8, 2019, the U.S. Department of Treasury and the IRS released the 2019-2020 “Priority Gu...

Read More >

Restaurant “Service Duties” Bill Fails to Get Veto Override; “Deal” Being Sought

A bill that would have brought the state’s tipping regulations in line with federal regulations was...

Read More >

FTC Announces 2020 Thresholds for Merger Control Filings Under HSR Act and Interlocking Directorates Under the Clayton Act

The Federal Trade Commission (“FTC”) has announced its annual revisions to the dollar jurisdiction...

Read More >

[Video] Accountability: At the Heart of Compliance-Boeing, Part 3-Creating An Accountable World

We have been getting accountability all wrong in the compliance profession. It's not a set of tasks ...

Read More >

Coronavirus Concerns Continue as CDC Issues Additional Travel Notices

As employers are likely aware, cases of the 2019 Novel Coronavirus (also referred to as COVID-19, bu...

Read More >